View in EDS

Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals.

Saved in:
Bibliographic Details
Title: Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals.
Authors: Galasko DR; Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA. dgalasko@ucsd.edu, Graff-Radford N, May S, Hendrix S, Cottrell BA, Sagi SA, Mather G, Laughlin M, Zavitz KH, Swabb E, Golde TE, Murphy MP, Koo EH
Source: Alzheimer disease and associated disorders [Alzheimer Dis Assoc Disord] 2007 Oct-Dec; Vol. 21 (4), pp. 292-9.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8704771 Publication Model: Print Cited Medium: Print ISSN: 0893-0341 (Print) Linking ISSN: 08930341 NLM ISO Abbreviation: Alzheimer Dis Assoc Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 18090435
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Galasko+DR%22">Galasko DR</searchLink>; Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA. dgalasko@ucsd.edu<br /><searchLink fieldCode="AU" term="%22Graff-Radford+N%22">Graff-Radford N</searchLink><br /><searchLink fieldCode="AU" term="%22May+S%22">May S</searchLink><br /><searchLink fieldCode="AU" term="%22Hendrix+S%22">Hendrix S</searchLink><br /><searchLink fieldCode="AU" term="%22Cottrell+BA%22">Cottrell BA</searchLink><br /><searchLink fieldCode="AU" term="%22Sagi+SA%22">Sagi SA</searchLink><br /><searchLink fieldCode="AU" term="%22Mather+G%22">Mather G</searchLink><br /><searchLink fieldCode="AU" term="%22Laughlin+M%22">Laughlin M</searchLink><br /><searchLink fieldCode="AU" term="%22Zavitz+KH%22">Zavitz KH</searchLink><br /><searchLink fieldCode="AU" term="%22Swabb+E%22">Swabb E</searchLink><br /><searchLink fieldCode="AU" term="%22Golde+TE%22">Golde TE</searchLink><br /><searchLink fieldCode="AU" term="%22Murphy+MP%22">Murphy MP</searchLink><br /><searchLink fieldCode="AU" term="%22Koo+EH%22">Koo EH</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228704771%22">Alzheimer disease and associated disorders</searchLink> [Alzheimer Dis Assoc Disord] 2007 Oct-Dec; Vol. 21 (4), pp. 292-9.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8704771 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0893-0341 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208930341%22">08930341 </searchLink><i>NLM ISO Abbreviation: </i>Alzheimer Dis Assoc Disord <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=18090435
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/WAD.0b013e31815d1048
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 292
    Titles:
      – TitleFull: Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Galasko DR
      – PersonEntity:
          Name:
            NameFull: Graff-Radford N
      – PersonEntity:
          Name:
            NameFull: May S
      – PersonEntity:
          Name:
            NameFull: Hendrix S
      – PersonEntity:
          Name:
            NameFull: Cottrell BA
      – PersonEntity:
          Name:
            NameFull: Sagi SA
      – PersonEntity:
          Name:
            NameFull: Mather G
      – PersonEntity:
          Name:
            NameFull: Laughlin M
      – PersonEntity:
          Name:
            NameFull: Zavitz KH
      – PersonEntity:
          Name:
            NameFull: Swabb E
      – PersonEntity:
          Name:
            NameFull: Golde TE
      – PersonEntity:
          Name:
            NameFull: Murphy MP
      – PersonEntity:
          Name:
            NameFull: Koo EH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2007 Oct-Dec
              Type: published
              Y: 2007
          Identifiers:
            – Type: issn-print
              Value: 0893-0341
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Alzheimer disease and associated disorders
              Type: main
ResultId 1